ReviewCurrent oncology (Toronto, Ont.)2021

Neoadjuvant Therapy in Lung Cancer: What Is Most Important: Objective Response Rate or Major Pathological Response?

Xi Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.